(Reuters) -German packaging and medical equipment maker Gerresheimer reported a lower organic core profit for the first quarter on Friday, hit by continued lower demand in moulded glass and shift in syringe revenues into later quarters.
Its adjusted operating earnings before depreciation and amortisation (EBITDA) were 91.4 million euros ($103.29 million) including recently acquired Bormioli Pharma. They were down 9.3% on an organic basis compared to the same period last year.
($1 = 0.8849 euros)
(Reporting by Isabel Demetz and Marleen Kaesebier in Gdansk, editing by Milla Nissi)
Comments